A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid Hemorrhage

Nimodipine is the only drug approved for use by the Food and Drug Administration for improving outcome after aneurysmal subarachnoid hemorrhage (SAH). It has less than optimal efficacy, causes dose-limiting hypotension in a substantial proportion of patients, and is administered enterally 6 times da...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neurotherapeutics
Egile Nagusiak: Hänggi, Daniel, Etminan, Nima, Steiger, Hans Jakob, Johnson, Mark, Peet, M. Melissa, Tice, Tom, Burton, Kevin, Hudson, Bruce, Turner, Michele, Stella, Angela, Heshmati, Parissa, Davis, Cara, Faleck, Herbert J., Macdonald, R. Loch
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer US 2016
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4824023/
https://ncbi.nlm.nih.gov/pubmed/26935204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-016-0424-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak